Microvascular dysfunction: what have we learned from WISE?

References

• Likoff W, Segal BL, Kasparian H. Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease. N. Engl. J. Med.276(19), 1063–1066 (1967).
   PubMed Web of Science ®Google Scholar
• Cannon RO 3rd, Watson RM, Rosing DR, Epstein SE. Angina caused by reduced vasodilator reserve of the small coronary arteries. J. Am. Coll. Cardiol.1(6), 1359–1373 (1983).
   PubMed Web of Science ®Google Scholar
• Campbell DJ, Somaratne JB, Jenkins AJ et al. Differences in myocardial structure and coronary microvasculature between men and women with coronary artery disease. Hypertension57(2), 186–192 (2011).
   PubMedGoogle Scholar
• Reis SE, Holubkov R, Lee JS et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women’s Ischemia Syndrome Evaluation (WISE) study. J. Am. Coll. Cardiol.33(6), 1469–1475 (1999).
   PubMed Web of Science ®Google Scholar
• Gulati M, Cooper-DeHoff RM, McClure C et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch. Intern. Med.169(9), 843–850 (2009).
   PubMedGoogle Scholar
• Carpiuc KT, Wingard DL, Kritz-Silverstein D, Barrett-Connor E. The association of angina pectoris with heart disease mortality among men and women by diabetes status: the Rancho Bernardo Study. J. Womens Health (Larchmt.)19(8), 1433–1439 (2010).
   PubMed Web of Science ®Google Scholar
• Hemingway H, Langenberg C, Damant J et al. Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation117(12), 1526–1536 (2008).
   PubMedGoogle Scholar
• Jespersen L, Hvelplund A, Abildstrom SZ et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur. Heart J. doi:10.1093/eurheartj/ehr331 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Pepine CJ, Anderson RD, Sharaf BL et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J. Am. Coll. Cardiol.55(25), 2825–2832 (2010).
   PubMed Web of Science ®Google Scholar
• Doyle M, Weinberg N, Pohost GM et al. Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women’s Ischemia Syndrome Evaluation) study. JACC Cardiovasc. Imaging3(10), 1030–1036 (2010).
   PubMed Web of Science ®Google Scholar
• Buchthal SD, den Hollander JA, Merz CN et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N. Engl. J. Med.342(12), 829–835 (2000).
   PubMed Web of Science ®Google Scholar
• Johnson BD, Shaw LJ, Buchthal SD et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health–National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation109(24), 2993–2999 (2004).
   PubMed Web of Science ®Google Scholar
• Mohandas R, Handberg EM, Bairey Merz CN et al. CD34+ cell number and function predicts coronary flow reserve and is a potential biomarker for microvascular coronary artery disease. Circulation122(21 Suppl.), A20380 (2010) (Abstract).
   Google Scholar
• Pauly DF, Johnson BD, Anderson RD et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE). Am. Heart J.162(4), 678–684 (2011).
   PubMedGoogle Scholar
• Bavry AA, Handberg EM, Wen X et al. Does angiotensin plus aldosterone inhibition improve coronary endothelial function? An ancillary study from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE). J. Am. Coll. Cardiol.57(14 Suppl. 1), E1047 (2011) (Abstract).
   Google Scholar
• Denardo SJ, Wen X, Handberg EM et al. Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women’s Ischemia Syndrome Evaluation (WISE) ancillary study. Clin. Cardiol.34(8), 483–487 (2011).
   PubMedGoogle Scholar
• Balcells M, Martorell J, Olive C et al. Smooth muscle cells orchestrate the endothelial cell response to flow and injury. Circulation121(20), 2192–2199 (2010).
   PubMed Web of Science ®Google Scholar
• Golino P, Piscione F, Willerson JT et al. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N. Engl. J. Med.324(10), 641–648 (1991).
   PubMed Web of Science ®Google Scholar
• Park K, Egelund E, Wen X et al. Serotonin transporter gene polymorphism in women with suspected ischemia: a report from the NHLBI-sponsored WISE. Circulation122(21 Suppl.), A20055 (2010) (Abstract).
   Google Scholar
• Anderson TJ, Charbonneau F, Title LM et al. Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study. Circulation123(2), 163–169 (2011).
   PubMed Web of Science ®Google Scholar